2,131
Views
14
CrossRef citations to date
0
Altmetric
Commentary

Are we speaking the same language? an argument for the consistent use of terminology and definitions for childhood vaccination indicators

ORCID Icon, , , , , , & show all
Pages 740-747 | Received 18 Oct 2018, Accepted 30 Oct 2018, Published online: 20 Dec 2018

References

  • Friedman M. Trying hard is not enough. Charleston (SC, USA): Booksurge publishing; 2009.
  • Porta M. Dictionary of epidemiology. 5th. Cary (NC): Oxford University Press; 2008.
  • CDC Invasive pneumococcal disease and 13-Valent Pneumococcal Conjugate Vaccine (PCV13) coverage among children aged ≤59 months — selected U.S. Regions, 2010–2011. Morb Mortal Wkly Rep. 2011;60(43):1477–1481.
  • CDC: Morbidity and Mortality Weekly Report. Interim results: state-specific influenza vaccination coverage — United States, August 2010–february 2011.; 2011. www.cdc.gov/nis.
  • CDC. Rotavirus vaccination coverage among infants aged 5 months — immunization information system sentinel sites, United States, june 2006–june 2009. Morb Mortal Wkly Rep. 2010;59(17):521–524. http://www.cdc.gov/vaccines/programs/iis/
  • Theeten H, Vandermeulen C, Roelants M, Hoppenbrouwers K, Depoorter AM, Van Damme P. Coverage of recommended vaccines in children at 7-8 years of age in Flanders, Belgium. Acta Paediatr Int J Paediatr. 2009;98:.1307–1312. doi:10.1111/j.1651-2227.2009.01331.x.
  • Reuss A, Walter D, Feig M, Kappelmayer L, Buchholz U, Eckmanns T, Poggensee G. Influenza vaccination coverage in the 2004/05, 2005/06, 2006/07 Seasons A secondary data analysis based on billing data of the german associations of statutory health insurance physicians. Dtsch Arztebl Int. 2010;107(48):845–850.doi:10.3238/arztebl.2010.0845.
  • CDC. Global routine vaccination coverage, 2009. Morb Mortal Wkly Rep. 2010;59(42):1367–1371. http://www.jstor.org/stable/23320921
  • Schmidt M, Gold R, Kurosky S, Daley M, Irving S, Gee J, Naleway A. Uptake, coverage, and completion of quadrivalent human papillomavirus vaccine in the vaccine safety datalink, July 2006-June 2011. J Adolesc Heal. 2013;53:637–641. doi:10.1016/j.jadohealth.2013.08.002.
  • Pringle K, Cardemil CV, Pabst LJ, Parashar UD, Cortese MM. Uptake of rotavirus vaccine among US infants at immunization information system sentinel sites. Vaccine. 2016. doi:10.1016/j.vaccine.2016.10.005.
  • Lin X, Fiebelkorn AP, Pabst LJ. Trends in compliance with two-dose influenza vaccine recommendations in children aged 6 months through 8 years, 2010–2015. Vaccine. 2016;34:.5623–5628. doi:10.1016/j.vaccine.2016.09.037.
  • Schweitzer A, Akmatov MK, Krause G. Hepatitis B vaccination timing: results from demographic health surveys in 47 countries. Bull World Health Organ. 2017;95:199–209. doi:10.2471/BLT.16.178822.
  • Limia A, Pachón I. Coverage of human papillomavirus vaccination during the first year of its introduction in Spain. Eurosurveillance. 2011;16(21):pii=19873.
  • MacDonald SE, Bell CA, Simmonds KA. Coverage and determinants of uptake for privately funded rotavirus vaccine in a Canadian birth cohort, 2008-2013. Pediatr Infect Dis J. 2016;35:.e177–e179. doi:10.1097/INF.0000000000001125.
  • Uhlig U, Kostev K, Schuster V, Uhlig HH. Rotavirus vaccination in Germany: analysis of nationwide surveillance data 2006 to 2010. Pediatr Infect Dis J. 2011;30:.e244–e247. doi:10.1097/INF.0b013e31822d1408.
  • Streng A, Grote V, Carr D, Hagemann C, Liese JG. Varicella routine vaccination and the effects on varicella epidemiology - results from the bavarian varicella surveillance project (BaVariPro), 2006-2011. BMC Infect Dis. 2013;13. doi:10.1186/1471-2334-13-303
  • Effler P, Chu C, He H, Gaynor K, Sakamoto S, Nagao M, Mendez L, Park S. Statewide school-located influenza vaccination program for children 5-13 years of age, Hawaii, USA. Emerg Infect Dis. 2010;16:244–250. doi:10.3201/eid1602.091375.
  • Santibanez TA, Shefer A, Briere EC, Cohn AC, Groom AV. Effects of a nationwide Hib vaccine shortage on vaccination coverage in the United States. Vaccine. 2012;30:.941–947. doi:10.1016/j.vaccine.2011.11.075.
  • Jeannot E, Sudre P, Chastonay P. HPV vaccination coverage within 3 years of program launching (2008-2011) at Geneva State, Switzerland. Int J Public Health. 2012;57:.629–632. doi:10.1007/s00038-012-0352-2.
  • Giammanco G, Ciriminna S, Barberi I, Titone L. Lo Giudice M BL. Universal varicella vaccination in the Sicilian. Eurosurveillance. 2009;14(35):1–4.
  • CDC. National, state, and local area vaccination coverage among children aged 19–35 months — United States, 2012. Morb Mortal Wkly Rep. 2013;62(36): 733–740.
  • Riise ØR, Laake I, Bergsaker MAR, Nøkleby H, Haugen IL, Storsøter J. Monitoring of timely and delayed vaccinations: A nation-wide registry-based study of Norwegian children aged < 2 years. BMC Pediatr. 2015. doi:10.1186/s12887-015-0487-4.
  • Widgren K, Simonsen J, Valentiner-Branth P, Mølbak K. Uptake of the human papillomavirus-vaccination within the free-of-charge childhood vaccination programme in Denmark. Vaccine. 2011;29:.9663–9667. doi:10.1016/j.vaccine.2011.10.021.
  • Vaux S, Van Cauteren D, Guthmann J, Le Strat Y, Vaillant V, de Valk H, Lévy-Bruhl D. Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey. BMC Public Health. 2011;11:DOI: 10.1186/1471-2458-11-30.
  • Foisy J, Rosella LC, Sanderson R, Hamid JS, Dhar B, Crowcroft NS. Self-reported pH1N1 influenza vaccination coverage for OntarioHealth Rep. 2011;22(3): 29–33.
  • Weil-Olivier C, Lina B. Vaccination coverage with seasonal and pandemic influenza vaccines in children in France, 2009-2010 season. Vaccine. 2011;29:.7075–7079. doi:10.1016/j.vaccine.2011.07.018.
  • La Torre G, Iarocci G, Cadeddu C, Boccia A. Influence of sociodemographic inequalities and chronic conditions on influenza vaccination coverage in Italy: results from a survey in the general population. Public Health. 2010;124:.690–697. doi:10.1016/j.puhe.2010.06.006.
  • Kuchar E, Nitsch-Osuch A, Zycinska K, Miskiewicz K, Szenborn L, Wardyn K. Influenza immunization rates in children and teenagers in polish cities: conclusions from the 2009/2010 season. Adv Exp Med Biol. 2013;755:243–249. doi:10.1007/978-94-007-4546-9_31.
  • Kansagra SM, Papadouka V, Geevarughese A, Hansen MA, Konty KJ, Zucker JR. Reaching children never previously vaccinated for influenza through a school-located vaccination program. Am J Public Health. 2014;104:e45–e49. doi:10.2105/AJPH.2013.
  • Quach S, Hamid J, Pereira J, Heidebrecht C, Deeks S, Crowcroft N, Quan S, Brien S, Kwong J. Influenza vaccination coverage across ethnic groups in Canada. Can Med Assoc J. 2012;184:1673–1681. doi:10.1503/cmaj.111628.
  • Guthmann JP, Antoine D, Fonteneau L, Che D, Lévy-Bruhl D. Assessing bcg vaccination coverage and incidence of paediatric tuberculosis following two major changes in bcg vaccination policy in France. Eurosurveillance. 2011;16(12):pii=19824.
  • Nitsch-Osuch AWK. Influenza vaccine coverage in age-related risk groups in Poland, 2004–2007. Cent Eur J Public Heal. 2009;17(4):198–202. doi:10.1111/j.1600-0447.1959.tb08318.x.
  • Bone A, Guthmann JP, Nicolau J, Lévy-Bruhl D. Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign. Vaccine. 2010;28:.8157–8161. doi:10.1016/j.vaccine.2010.09.096.
  • Laz TH, Rahman M, Berenson AB. An update on human papillomavirus vaccine uptake among 11-17 year old girls in the United States: national health interview survey, 2010. Vaccine. 2012;30:.3534–3540. doi:10.1016/j.vaccine.2012.03.067.
  • Wong CA, Berkowitz Z, Dorell CG, Anhang Price R, Lee J, Saraiya M. Human papillomavirus vaccine uptake among 9- to 17-year-old girls: national health interview survey, 2008. Cancer. 2011;117:.5612–5620. doi:10.1002/cncr.26246.
  • Reiter PL, McRee AL, Pepper JK, Gilkey MB, Galbraith KV, Brewer NT. Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males. Am J Public Health. 2013;103(8):1419–1427. doi:10.2105/AJPH.2012.301189.
  • Reiter PL, Gilkey MB, Brewer NT. HPV vaccination among adolescent males: results from the national immunization survey-teen. Vaccine. 2013;31:.2816–2821. doi:10.1016/j.vaccine.2013.04.010.
  • Poole T, Goodyear-Smith F, Petousis-Harris H, Desmond N, Exeter D, Pointon L, Jayasinha R. Human papillomavirus vaccination in Auckland: reducing ethnic and socioeconomic inequities. Vaccine. 2012;31:84–88. doi:10.1016/j.vaccine.2012.10.099.
  • Garland SM, Skinner SR, Brotherton JML. Adolescent and young adult HPV vaccination in Australia: achievements and challenges. Prev Med (Baltim). 2011;53:.S29–S35. doi:10.1016/j.ypmed.2011.08.015.
  • First Nations and Inuit Health Branch – Alberta Region. Regional Communicable Disease Control Report, 2016, Ottawa: Health Canada, 2017.
  • Reiter P, McRee AGS. Correlates of receiving recommended adolescent vaccines among adolescent females in North Carolina. Hum Vaccin. 2011;7(1):67–73.
  • Dummer T, Cui Y, Strang RPL. Immunization completeness of children under two years of age in Nova Scotia, Canada. Cpha. 2012;103(5):363–367.
  • Sakou II, Tsitsika AK, Papaevangelou V, Tzavela EC, Greydanus DE, Tsolia MN. Vaccination coverage among adolescents and risk factors associated with incomplete immunization. Eur J Pediatr. 2011;170:.1419–1426. doi:10.1007/s00431-011-1456-z.
  • Lowther S, Shinoda N, Juni B, Theodore M, Wang X, Jawahir S, Jackson M, Cohn A, Danila R, Lynfield R. Haemophilus influenzae type b infection, vaccination, and H. influenzae carriage in children in Minnesota, 2008-2009. Epidemiol Infect. 2012;140:566–574. doi:10.1017/S0950268811000793.
  • Ernst KC, Pogreba-Brown K, Rasmussen L, Erhart LM. The effect of policy changes on hepatitis a vaccine uptake in Arizona children, 1995-2008. Public Health Reports. 2011;126:87–96.
  • CDC. Principles of Epidemiology in Public Health Practice, Third Edition An Introduction to Applied Epidemiology and Biostatistics. Atlanta, GA: CDC, 2012.
  • Tennis P, Toback SL, Andrews EB, McQuay LJ, Ambrose CS. A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years. Vaccine. 2011;29:4947–4952. doi:10.1016/j.vaccine.2012.07.031.
  • Happe LE, Lunacsek OE, Kruzikas DT, Marshall GS. Impact of a pentavalent combination vaccine on immunization timeliness in a state medicaid population. Pediatr Infect Dis J. 2009;28:.98–101. doi:10.1097/INF.0b013e318187d047.
  • Kramer MR, Dunlop AL. Inter-state variation in human papilloma virus vaccine coverage among adolescent girls in the 50 US States, 2007. Matern Child Health J. 2012;16:.102–110. doi:10.1007/s10995-012-0999-6.
  • Dempsey A, Cohn L, Dalton V, Ruffin M. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine. 2010;28:.989–995. doi:10.1016/j.vaccine.2009.10.133.
  • Staras SAS, Vadaparampil ST, Haderxhanaj LT, Shenkman EA. Disparities in human papillomavirus vaccine series initiation among adolescent girls enrolled in florida medicaid programs, 2006-2008. J Adolesc Heal. 2010;47:.381–388. doi:10.1016/j.jadohealth.2010.07.028.
  • Moss JL, Gilkey MB, Reiter PL, Brewer NT. Trends in HPV vaccine initiation among adolescent females in North Carolina, 2008-2010. Cancer Epidemiol Biomarkers Prev. 2012;21:.1913–1922. doi:10.1158/1055-9965.EPI-12-0509.
  • Eberth JM, Hossain MM, Tiro JA, Zhang X, Holt JB, Vernon SW. human papillomavirus vaccine coverage among females aged 11 to 17 in Texas Counties: an application of multilevel, small area estimation. Women’s Heal Issues. 2013;23. doi:10.1016/j.whi.2012.12.005
  • Human Papillomavirus CDC. vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013 United States. Morb Mortal Wkly Rep. 2007;62(29):591–595. http://www.cdc.gov/mmwr/preview/mmwrluml/rr5602a1.htm.
  • Taylor SD, Hariri S, Sternberg M, Dunne EF, Markowitz LE. Human papillomavirus vaccine coverage in the United States, national health and nutrition examination survey, 2007-2008. Prev Med (Baltim). 2011;52:398–400. doi:10.1016/j.ypmed.2010.11.006.
  • Pathela P, Jamison K, Papadouka V, Kabir R, Markowitz L, Dunne E, Schillinger J. Measuring adolescent human papillomavirus vaccine coverage: a match of sexually transmitted disease clinic and immunization registry Data. J Adolesc Heal. 2016;59:710–715. doi:10.1016/j.jadohealth.2016.07.021.
  • Hug S, Weibel D, Delaporte E, Gervaix A, Heininger U. Comparative coverage of supplementary and universally recommended immunizations in children at 24 months of age. Pediatr Infect Dis J. 2012;31:217–220. doi:10.1097/INF.0b013e31823cbaa5.
  • Hull B, Dey A, Campbell-Lloyd BS, Menzies RI, Mcintyre PB. NSW annual immunisation coverage report, 2010. NSW Public Heal Bull. 2011;22(9–10):179–195. doi:10.1071/NB11021.
  • National Advisory Committee on Immunization (NACI). Update on the recommended Human Papillomavirus (HPV) vaccine immunization schedule.; 2015. https://www.canada.ca/en/public-health/services/publications/healthy-living/update-recommended-human-papillomavirus-vaccine-immunization-schedule.html.
  • Denizot S, Fleury J, Caillaux G, Rouger V, Rozé JC, Le GCG. Hospital initiation of a vaccinal schedule improves the long-term vaccinal coverage of ex-preterm children. Vaccine. 2011;29:.382–386. doi:10.1016/j.vaccine.2010.11.006.
  • Stokley S, Cohn A, Jain N, McCauley MM. Compliance with recommendations and opportunities for vaccination at ages 11 to 12 years: evaluation of the 2009 national immunization survey-teen. Arch Pediatr Adolesc Med. 2011;165:.813. doi:10.1016/j.cell.2015.01.047.
  • White KE, Pabst LJ, Cullen KA. Up-to-date haemophilus influenzae type b vaccination coverage during a vaccine shortage. Pediatrics. 2011;127:.e707–e712. doi:10.1542/peds.2010-2129.
  • Greenwood VJ, Crawford NW, Walstab JE, Reddihough DS. Immunisation coverage in children with cerebral palsy compared with the general population. J Paediatr Child Health. 2013;49:.E137–E141. doi:10.1111/jpc.12097.
  • Madewell Z, Wester R, Wang W, Smith T, Michael Peddecord K, Morris J, Deguzman H, Sawyer M, McDonald E. Voluntarily reported immunization registry data: reliability and feasibility to predict immunization rates, San Diego, California, 2013. Public Health Rep. 2017;132:357–365. doi:10.1177/0033354917699827.
  • Opel DJ, Taylor JA, Zhou C, Catz S, Myaing M, Mangione-Smith R. The relationship between parent attitudes about childhood vaccines survey scores and future child immunization status: A validation study. JAMA Pediatr. 2013;167:.1065. doi:10.1001/jamapediatrics.2013.2483.
  • CDC. Vaccination coverage among children in Kindergarten — United States, 2009–10 school year. Morb Mortal Wkly Rep. 2011;60(21): 700–704. doi: 10.1016/j.wem.2010.11.007.
  • Smith PJ, Jain N, Stevenson J, Männikkö N, Molinari NA. Progress in timely vaccination coverage among children living in low-income households. Arch Pediatr Adolesc Med. 2009. doi:10.1001/archpediatrics.2009.25.
  • Stockwell MS, Martinez RA, Hofstetter A, Natarajan K, Vawdrey DK. Timeliness of 2009 H1N1 vaccine coverage in a low-income pediatric and adolescent population. Vaccine. 2013;31:.2103–2107. doi:10.1016/j.vaccine.2011.03.062.
  • Luman ET, Barker LE, Shaw KM, McCauley MM, Buehler JW, Pickering LK. Timeliness of childhood vaccinations in the United States: days undervaccinated and number of vaccines delayed. J Am Med Assoc. 2005;293:.1204. doi:10.1001/jama.293.10.1204.
  • Pabst LJ, Chaves SS, Weinbaum C. Brief report trends in compliance with two-dose influenza vaccine recommendations among children aged 6 months through 8 years. Vaccine. 2013;31:3116–3120. doi:10.1016/j.vaccine.2013.04.080.
  • O’Grady KA, Krause V, Andrews R. Immunisation coverage in Australian indigenous children: time to move the goal posts. Vaccine. 2009;27:.307–312. doi:10.1016/j.vaccine.2008.09.096.
  • Moran K, Maaten S, Guttmann A, Northrup D, Kwong JC. Influenza vaccination rates in Ontario children: implications for universal childhood vaccination policy. Vaccine. 2009;27:.2350–2355. doi:10.1016/j.vaccine.2009.02.017.
  • Valcarcel Salamanca B, Hagerup-Jenssen ME, Flem E. Uptake and timeliness of rotavirus vaccination in Norway: the first year post-introduction. Vaccine. 2016;34:.4684–4689. doi:10.1016/j.vaccine.2016.08.017.
  • Nelson J, Bittner R, Bounds L, Zhao S, Baggs J, Donahue J, Hambidge S, Jacobsen S, Klein N, Naleway A, et al. Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study. Am J Public Health. 2009;99:S389–S397. doi:10.2105/AJPH.2008.151332.
  • Bell CA, Simmonds KA, MacDonald SE. Exploring the heterogeneity among partially vaccinated children in a population-based cohort. Vaccine. 2015;33:.4572–4578. doi:10.1016/j.vaccine.2015.07.004.